EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)

Rodrigo E Mendes iD, S J Ryan Arends iD, Jennifer M Streit iD, Ian Critchley, Nicole Cotroneo iD, Mariana Castanheira iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02057-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Rodrigo E Mendes und 5 weiteren Autor:innen. Beteiligte Einrichtung: JMI Laboratories, North Liberty, Iowa, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Urinary Tract Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS, Spero Therapeutics, Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The occurrence of urinary-tract Enterobacterales pathogens producing ESBL enzymes in community and nosocomial settings continues to increase, as does the coresistance to fluoroquinolones, trimethoprim-sulfamethoxazole and nitrofurantoin often exhibited by these pathogens. This scenario complicates the clinical empirical and guided management of UTI by precluding the use of oral and many intravenous options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsUrinary Tract InfectionsHumansErtapenemEscherichia coliCeftriaxoneAztreonamTrimethoprim, Sulfamethoxazole Drug CombinationCarbapenemsKlebsiella pneumoniaeHospitalsMicrobial Sensitivity Testsbeta-Lactamases

Stichwörter der Autor:innen

CTX-MGram-negative bacteriaresistancesurveillance

Substanzen

tebipenemAnti-Bacterial AgentsErtapenemCeftriaxoneAztreonamTrimethoprim, Sulfamethoxazole Drug CombinationCarbapenemsbeta-Lactamases

Autor:innen und Institutionen

  • JMI Laboratories, North Liberty, Iowa, USA.
  • Spero Therapeutics, Cambridge, Massachusetts, USA.

ORCID-Profile: Rodrigo E Mendes, S J Ryan Arends, Jennifer M Streit, Nicole Cotroneo, Mariana Castanheira

Förderung

  • HHS
  • Spero Therapeutics
  • Department of Health and Human Services

Zitieren

APA

Mendes, R. E., Arends, S. J. R., Streit, J. M., Critchley, I., Cotroneo, N., & Castanheira, M. (2023). Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020). Microbiology Spectrum. https://doi.org/10.1128/spectrum.02057-22

Vancouver

Mendes RE, Arends SJR, Streit JM, Critchley I, Cotroneo N, Castanheira M. Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020). Microbiology Spectrum. 2023. doi:10.1128/spectrum.02057-22

BibTeX
@article{Mendes2023,
  author = {Mendes, Rodrigo E and Arends, S J Ryan and Streit, Jennifer M and Critchley, Ian and Cotroneo, Nicole and Castanheira, Mariana},
  title = {Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02057-22}
}
Kostenlos starten →